Most U.S. Medical Schools Have Strong Pharmaceutical Conflict-Of-Interest Policies: Medical Student, Pew Survey
The majority of U.S. medical schools have implemented strong conflict-of-interest policies this year, according to the 2010 American Medical Student Association (AMSA) PharmFree Scorecard, released today. The Scorecard, developed by AMSA and the Pew Prescription Project, provides an in-depth analysis of the nation’s medical schools’ policies governing pharmaceutical industry interaction with medical school faculty and students.
Reston, VA (PRWEB) December 15, 2010
The majority of U.S. medical schools have implemented strong conflict-of-interest policies this year, according to the 2010 American Medical Student Association (AMSA) PharmFree Scorecard, released today. The Scorecard, developed by AMSA and the Pew Prescription Project, finds that 79 of 152 medical schools (52%) now receive a grade of A or B for their policies governing pharmaceutical industry interaction with medical school faculty and students, compared with 45 last year.
The AMSA PharmFree Scorecard (http://www.amsascorecard.org), now in its fourth year, offers a comprehensive national overview, as well as an in-depth, school-by-school analysis in 11 areas, including gifts and meals from industry to doctors, paid promotional speaking for industry, acceptance of free drug samples, interaction with sales representatives and industry-funded education.
Of the 152 U.S. medical schools, 19 receive As (13%), 60 Bs (39%), 24 Cs (16%), 18 Ds (12%) and 26 Fs (17%). Schools that declined to submit policies and schools that did not respond to repeated requests for policies received an automatic ‘F’ (12 schools). Five respondents received a grade of “In Process” because their policies are currently under review or revision.
Highlights of the survey include:
- The University of South Dakota, Des Moines College of Osteopathic Medicine and Tufts University School of Medicine have increased from ‘D’ policies to ‘A’ policies this year. Tufts is now the highest scoring medical school in Massachusetts.
- The University of New England College of Osteopathic Medicine, increased its grade from a ‘F’ to a ‘C’.
- The University of Central Florida College of Medicine, which only opened its doors in 2009, received a ‘B’.
- There are only two medical schools that received a perfect score for limiting access of sales representatives – the University of South Dakota Sanford School of Medicine and Florida State University College of Medicine.
- Nearly one-third of medical schools now teach medical students to understand institutional conflict of interest policies, to recognize how industry promotion and marketing can influence clinical judgment and to consider the ethics around conflict of interest.
The other top-ranked, (‘A’) schools in the 2010 report include: Mount Sinai School of Medicine (New York), University of Pittsburgh Medical Center, University of California Los Angeles David Geffen School of Medicine, University of Pennsylvania School of Medicine, University of California Davis School of Medicine, University of California San Francisco School of Medicine, University of Texas Medical Branch at Galveston, Johns Hopkins School of Medicine, University of Maryland School of Medicine, Mayo Medical School, University of Iowa Carver College of Medicine, Emory University School of Medicine, University of Miami Miller School of Medicine, Georgetown University School of Medicine, Stanford University School of Medicine, and the University of Southern California Keck School of Medicine.
“As conflict-of-interest policies become part of mainstream medical education, this is an exciting time for future physicians and the health care industry as a whole,” says John Brockman, AMSA national president and fourth year medical student at Case Western Reserve University School of Medicine. “With all of the compelling data about how marketing influences even the best-intentioned physicians, it is gratifying to see that medical schools are taking the necessary steps toward practicing evidence-based medicine, which translates into better patient care.” Case Western increased its grade this year from a ‘D’ to a ‘B’.
AMSA developed the rigorous scorecard methodology with the Pew Prescription Project, which works to promote consumer safety through reforms in the approval, manufacture and marketing of prescription drugs.
“Conflict of interest policies ensure appropriate relationships between caregivers and drug and medical device companies,” said Allan Coukell, director of medical safety for the Pew Health Group, which supports AMSA’s work. “The 2010 Scorecard shows that medical schools are moving toward stronger conflict-of-interest standards and that the Scorecard is an increasingly accepted assessment tool.”
Virtual News Conference
On Wednesday, December 15th at 11 a.m. EST/8 a.m. PST, AMSA will host a virtual news conference to review the results of the 2010 AMSA PharmFree Scorecard:
Toll Free Access Number: